Eastern Virginia Medical School Receives $100M Grant From USAID For Microbicide Research
Main Category: HIV / AIDSAlso Included In: Clinical Trials / Drug Trials; Sexual Health / STDs; Women's Health / Gynecology
Article Date: 10 Sep 2008 - 5:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
2 (1 votes) |
| Article Opinions: | 1 posts |
Eastern Virginia Medical School on Monday announced that it has received a $100 million grant from USAID for microbicide research through its CONRAD program, the Virginian-Pilot reports. According to EVMS, the grant will help its more than 20 years of research into microbicides. "It's an extraordinary grant," Gustavo Doncel, pre-clinical director for CONRAD, said, adding, "Our main goal with the grant is to improve reproductive health in developing countries." According to Doncel, CONRAD researchers are focusing on several microbicide candidates(Simpson, Virginian-Pilot, 9/8).
The funding will be distributed at $20 million annually for five years to help pay for microbicide trials, according to Reuters. Two candidates that CONRAD is researching are a microbicide that uses the antiretroviral drug tenofovir and another experimental candidate called UC781(Fox, Reuters, 9/8).
CONRAD also is researching combination products that not only would provide protection against HIV but also would prevent other sexually transmitted infections and unplanned pregnancies. In addition, researchers aim to develop products that will be effective over longer periods of time, rather than applying the microbicide before sex, Doncel said. He added that he expects it will take another 10 years before a microbicide is available on the market. CONRAD Executive Director Henry Gabelnick said that the program has received about $400 million in grants for its work (Virginian-Pilot, 9/8).
According to a USAID spokesperson, the agency receives about $40 million annually from Congress for microbicide development and provides funding to several programs, including the Population Council and the International Partnership for Microbicides (Reuters, 9/8).
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.
© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Visit our hiv / aids section for the latest news on this subject.
MLA
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/120942.php>
APA
http://www.medicalnewstoday.com/releases/120942.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Men Need Microbicides Too
posted by Jim Pickett on 12 Sep 2008 at 9:21 amIt is important to note that microbicide research is important for men as well.
Rectal microbicides that are safe, effective and acceptable need to be developed for gay men and men who have sex with men who engage in anal intercourse. They also need to be developed for women - since many women in this country and around the world practice anal intercourse, most of which is unprotected and very risky.
An act of unprotected anal intercourse is 5 to 80 times more likely to end in HIV transmission compared to an act of unprotected vaginal intercourse.
To learn more about rectal microbicides, I encourage you to visit the website of the International Rectal Microbicide Advocates - http://www.rectalmicrobicides.org.
Thank you.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




